| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| Gross Profit | $50K | +997.5% | +113.8% |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $1.9M | -54.0% | -3.0% |
| Operating Income | -$2.6M | +43.2% | -0.1% |
| Interest Expense | $35K | -78.0% | -96.2% |
| Pre-tax Income | -$22.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.9M | +5248.4% | +2460.2% |
| Accounts Receivable | $0 | — | -100.0% |
| Inventory | $0 | — | -100.0% |
| Current Assets | $11.1M | +543.7% | +376.0% |
| Total Assets | $13.2M | +430.5% | +68.3% |
| Current Liabilities | $41.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.1M | — | — |
| Capital Expenditures | $600K | — | — |
| Investing Cash Flow | -$4.0M | — | — |
| Financing Cash Flow | $17.6M | — | — |
| Free Cash Flow | -$7.7M | — | — |
| -412.2% |
| Income Tax | $0 | — | — |
| Net Income | -$22.4M | -83.4% | -412.2% |
| EPS (Basic) | -$0.20 | -11.1% | +82.1% |
| EPS (Diluted) | -$0.20 | -11.1% | +82.1% |
| -4.6% |
| +167.2% |
| Total Liabilities | $67.0M | +41.9% | +230.6% |
| Stockholders' Equity | -$53.9M | -20.4% | -48.2% |